24 patient data entries collated from reference Ashley et al, 2008. Entry # | Mutations | allele 1 | allele 2 |
| Clinical representation | Symptoms | Age group | Patient age | Age of onset | Age of death | | 19 | T251I P587L2
| R232G4
| Alpers, epilepsy and hepatopathy, onset 5 months of age. | | | n/a | 0.5 | n/a | 72 | A467T2
| R417T1
| onset at 2 years with encephalopathy no hepatopathy. | | | n/a | 2 | n/a | 73 | A467T2
| C418R1
| Onset at 3 years of age, encephalopathy presenting with epilepsy and movement disorder (ataxia). | - | movement disorder (ataxia) | |
| | n/a | 3 | n/a | 106 | L966R1
| A467T2
| Reported as Alpers, onset at 4 years, presenting encephalopathy with epilepsy. | | | n/a | 4 | n/a | 135 | H569Q2
| H569Q2
| Onset 15 years presenting encephalopathy, no epilepsy or hepatopathy. 78% mtDNA copy number in muscle. | | | n/a | 15 | n/a | 137 | W748S5
| P587L2 P589L2
| Encephalopathy onset 16 years of age, presented with epilepsy. | | | n/a | 16 | n/a | 142 | T914P1
| R627W5
| reported as Alpers, onset at birth, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 5% mtDNA copy number in liver, 54% mtDNA copy number in muscle. | - | movement disorder (ataxia) | |
| | n/a | 0.01 | n/a | 156 | W748S5
| W748S5
| reported as Alpers, onset at 16 years, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 108% mtDNA copy number in muscle. | - | movement disorder (ataxia) | |
| | n/a | 16 | n/a | 174 | G848S1
| W748S5
| Reported as Alpers, onset at 6 years, presenting encephalopathy with epilepsy, hepatopathy absent, and movement disorder (ataxia). | - | movement disorder (ataxia) | |
| | n/a | 6 | n/a | 187 | W748S5
| R852C1 G11D
| reported as Alpers, onset at 1 years, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 32% mtDNA copy number in liver. | - | movement disorder (ataxia) | |
| | n/a | 1 | n/a | 188 | A467T2
| R852C1 G11D
| reported as Alpers, onset at 2 years, presenting encephalopathy with epilepsy, hepatopathy. 22% mtDNA copy number in muscle. | | | n/a | 2.25 | n/a | 197 | W748S5
| T914P1
| reported as Alpers, onset at 4 years, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 15% mtDNA copy number in liver. | - | movement disorder (ataxia) | |
| | n/a | 4 | n/a | 198 | A467T2
| T914P1
| reported as Alpers, onset at 7 months, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 39% mtDNA copy number in muscle. | - | movement disorder (ataxia) | |
| | n/a | 0.58 | n/a | 199 | R1096C3
| T914P1
| reported as Alpers, onset at <1 year, presenting encephalopathy with epilepsy, hepatopathy, and movement disorder (ataxia). 7% mtDNA copy number in liver, 23% mtDNA copy number in muscle | - | movement disorder (ataxia) | |
| | n/a | 1 | n/a | 235 | T851A1
| H277L3
| Onset at 6 months of age, epilepsy, hepatopathy. 4% mtDNA copy number in liver, 32% mtDNA copy number in muscle. | | | n/a | 0.5 | n/a | 648 | Nonsense mutation: R374X
| A467T2
| Epilepsy, hepatopathy, movement disorder (present but not prominent) | - | movement disorder (ataxia) | |
| | n/a | 0.33 | n/a | 649 | Indel: W347_L365del
| A467T2
| Epilepsy, hepatopathy, movement disorder (present but not prominent) | - | movement disorder (ataxia) | |
| | n/a | 0.58 | n/a | 683 | R1096C3
| R1096C3
| Epilepsy, Cellular depletion, Hepatopathy | | | n/a | 0.42 | n/a | 684 | Nonsense mutation: E873X
| A467T2
| mtDNA depletion (30% in muscle), epilepsy, hepatopathy, movement disorder | - | movement disorder (ataxia) | |
| | n/a | 1.5 | n/a | 685 | L304R3
| L304R3
| Relatively Mild phenotype | | | n/a | 10 | n/a | 687 | T914P1
| W748S5
| mtDNA depletion in muscle, Epilepsy, hepatopathy, movement disorder | - | movement disorder (ataxia) | |
| | n/a | 1.1 | n/a | 688 | T914P1
| A467T2
| Hepatopathy | | | n/a | 15 | n/a | 689 | G848S1
| A467T2
| Hepatopathy, Epilepsy, Hepatopathy, | | | n/a | 1.5 | n/a | 690 | A467T2
| A467T2
| Epilepsy, ataxia | - | movement disorder (ataxia) | |
| | n/a | 16 | n/a |
1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.
|